Ampio Pharmaceuticals Inc. (AMPE)

0.45
AMEX : Health Technology
Prev Close 0.45
Day Low/High 0.44 / 0.49
52 Wk Low/High 0.36 / 1.31
Avg Volume 686.90K
Exchange AMEX
Shares Outstanding 142.21M
Market Cap 64.41M
EPS 0.50
P/E Ratio 0.94
Div & Yield N.A. (N.A)

Latest News

Ampio Pharmaceuticals Updates Progress Of SPA Clinical Trial

Ampio Pharmaceuticals Updates Progress Of SPA Clinical Trial

ENGLEWOOD, Colo., Sept.

Ampio Pharmaceuticals Updates Progress Of SPA Clinical Trial

Ampio Pharmaceuticals Updates Progress Of SPA Clinical Trial

ENGLEWOOD, Colo., July 25, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Appoints Moss Adams LLP As The Company's New Independent Auditor

Ampio Appoints Moss Adams LLP As The Company's New Independent Auditor

ENGLEWOOD, Colo., July 11, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Appoints Dan Stokely As The Company's New Chief Financial Officer

Ampio Appoints Dan Stokely As The Company's New Chief Financial Officer

ENGLEWOOD, Colo., July 10, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals Announces Closing Of $12 Million Public Offering

Ampio Pharmaceuticals Announces Closing Of $12 Million Public Offering

ENGLEWOOD, Colo., June 19, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals Announces Pricing Of Public Offering

Ampio Pharmaceuticals Announces Pricing Of Public Offering

ENGLEWOOD, Colo., June 17, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock

Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock

ENGLEWOOD, Colo., June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Regulatory And Clinical Update

Ampio Regulatory And Clinical Update

ENGLEWOOD, Colo., June 14, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Clinical, Regulatory And Corporate Update

Ampio Clinical, Regulatory And Corporate Update

ENGLEWOOD, Colo., May 22, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals Provides Regulatory Update

Ampio Pharmaceuticals Provides Regulatory Update

ENGLEWOOD, Colo., April 29, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc.

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc.

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Ampio Pharmaceuticals, Inc. Investors (AMPE)

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Ampio Pharmaceuticals, Inc. Investors (AMPE)

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of Ampio Pharmaceuticals, Inc.

First Week Of AMPE January 2021 Options Trading

First Week Of AMPE January 2021 Options Trading

Investors in Ampio Pharmaceuticals Inc saw new options begin trading this week, for the January 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 850 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors Of Important Deadline In First Filed Case Commenced By Firm - AMPE

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors Of Important Deadline In First Filed Case Commenced By Firm - AMPE

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc.

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Ampio Pharmaceuticals, Inc. - AMPE

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Ampio Pharmaceuticals, Inc. - AMPE

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ampio Pharmaceuticals, Inc.

AMPE June 15th Options Begin Trading

AMPE June 15th Options Begin Trading

Investors in Ampio Pharmaceuticals Inc saw new options begin trading today, for the June 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 133 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting AMPE Put And Call Options For March 16th

Interesting AMPE Put And Call Options For March 16th

Investors in Ampio Pharmaceuticals Inc saw new options become available this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMPE options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

Interesting AMPE Put And Call Options For February 2018

Interesting AMPE Put And Call Options For February 2018

Investors in Ampio Pharmaceuticals Inc saw new options become available this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMPE options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Notable Monday Option Activity: AMPE, STRP, ENVA

Notable Monday Option Activity: AMPE, STRP, ENVA

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ampio Pharmaceuticals Inc , where a total of 1,453 contracts have traded so far, representing approximately 145,300 underlying shares. That amounts to about 81.2% of AMPE's average daily trading volume over the past month of 179,045 shares.

7 Stocks Under $10 That Could Make You a Lot of Money

7 Stocks Under $10 That Could Make You a Lot of Money

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Ampio Pharmaceuticals (AMPE) Weak On High Volume Today

Ampio Pharmaceuticals (AMPE) Weak On High Volume Today

Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate